Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Aldeyra Therapeu (ALDX)

Aldeyra Therapeu (ALDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Aldeyra Therapeu 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 USA

www.aldeyra.com P: 781-761-4904 F: 339-674-6495

Description:

Aldeyra Therapeutics, Inc. is a biotechnology company. The company's products target immune-mediated, inflammatory, orphan, and other diseases. It is developing NS2, a compound that binds and traps free aldehydes. Aldeyra Therapeutics, Inc. is based in Burlington, Massachusetts.

Key Statistics

Overview:

Market Capitalization, $K 234,091
Enterprise Value, $K 106,421
Shares Outstanding, K 59,414
Annual Sales, $ 0 K
Annual Net Income, $ -37,540 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -8,080 K
EBIT, $ -35,380 K
EBITDA, $ -35,130 K
60-Month Beta 1.45
% of Insider Shareholders 7.30%
% of Institutional Shareholders 59.71%
Float, K 55,077
% Float 92.70%
Short Volume Ratio 0.62

Growth:

1-Year Return -63.15%
3-Year Return -67.55%
5-Year Return -46.03%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 64.25%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.14 on 05/02/24
Latest Earnings Date N/A
Earnings Per Share ttm -0.51
EPS Growth vs. Prev Qtr -75.00%
EPS Growth vs. Prev Year 48.15%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

ALDX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -24.69%
Return-on-Assets % -20.26%
Profit Margin % 0.00%
Debt/Equity 0.13
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 2.18
Book Value/Share 1.91
Interest Coverage -17.14
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar